CLS · Celestica
Conviction · Low · more likely to lag the S&P 500 over the next three months
Wrong if: a daily close above $272.07
Note written ·
How this view changed
- · Rated Low. The note's kill line was crossed, 9 November 2026: CLS closed at $222.92 on 9 November 2026, below the $245 kill line in the previous note, and Bernstein cut its price target to $340 from $495.
Price against the kill line
11.7% clear of its kill line on the 13 November 2026 close.
How to read this
This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close above $272.07, on record since 11 November 2026. The shares are down 29.4% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close above $272.07, above every close since the 5 November 2026 low, which would show the rebound carrying the shares ahead of the S&P 500; or fourth-quarter 2026 revenue above the $6.575 billion top of guidance with a raised 2027 outlook.
Research onlyNot in the portfolio.
Catalyst
Key figures from the filings · Technology
Quarter to 30 September 2026, filed 26 October 2026; valuation at the 13 November 2026 close
- Revenue, latest quarter ($M)
- 5,830
- Revenue, change on a year (%)
- +82.5
- Gross margin (%)
- 11.0
- Operating margin (%)
- 7.9
- Free cash flow, four quarters ($M)
- 545
- Net cash, cash less debt ($M)
- 3,143
- Price to earnings (×)
- 24.3
- Enterprise value to sales (×)
- 1.5
All filed numbers
What Celestica reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Gross margin (%) | Operating margin (%) |
|---|---|---|---|---|
| first filed | 5,830 | +82.5 | 11.0 | 7.9 |
| first filed | 4,699 | +62.4 | 12.3 | 9.8 |
| first filed | 4,047 | +52.8 | 10.8 | 6.7 |
| first filed | 3,655 | +43.6 | 11.8 | 8.6 |
| first filed | 3,194 | +27.8 | 13.0 | 10.2 |
| first filed | 2,893 | +21.0 | 12.8 | 9.4 |
| Pre-tax income ($M) | 456 |
| Net income ($M) four quarters: 1,246 | 397 |
| Diluted shares, change on a year (%) against the quarter to 30 September 2025 | +5.1 |
| Operating cash flow ($M) | 1,408 |
| Capital spending ($M) | 862 |
| Free cash flow ($M) | 545 |
| Cash and short-term investments ($M) | 3,961 |
| Debt ($M) long-term debt and finance leases | 819 |
| Net cash, cash less debt ($M) | 3,143 |
| Deferred revenue ($M) at 30 June 2026, filed 27 July 2026; +21.4% on a year | 481 |
| Backlog, orders not yet delivered ($M) | Not reported |
| Receivables ($M) | Not reported |
| Inventory ($M) | 4,510 |
| Shareholders' equity ($M) | 6,214 |
| Market value ($M) | 30,310 |
| Enterprise value, market value plus net debt ($M) | 27,167 |
| Enterprise value to sales (×) | 1.5 |
| Enterprise value to operating income (×) | 18.1 |
| Price to earnings (×) | 24.3 |
| Price to book value (×) | 4.9 |
| Free-cash-flow yield (%) | 1.8 |
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 3.3% of shares outstanding sold short, 2.0 days of average trading to cover, −5.9% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $0 | $15.8M |
| 12 monthsfrom | $0 | $254.1M |
The thesis
Celestica is more likely to lag the S&P 500 over the next three months. Its business results are strong, but the shares are still in a decline that started at the June high. Nvidia's report on 17 November 2026 and Celestica's own fourth-quarter report, expected around 28 January 2027, show whether demand for AI hardware turns that decline. The rating is Low because a five-session rebound has not yet lifted the shares back to their 50-day or 200-day moving averages. The company also cut its 2026 free cash flow outlook, and analyst targets are still coming down.
The business case is unchanged since the 26 October 2026 report. Third-quarter revenue was $5.83 billion against guidance of $5.25–5.55 billion. Adjusted earnings per share (EPS) were $3.30 against guidance of $2.88–3.08. The company raised its 2026 outlook to $21.0 billion of revenue and $11.55 of adjusted EPS, and set 2027 targets of $40.0 billion of revenue and $21.50 of adjusted EPS.
The shares rebounded hard after the 5 November 2026 closing low of $205.64 and closed at $254.03 on 12 November 2026. MarketBeat reported volume of about 4.44 million shares on 11 November 2026, 76% above the daily average, and named no company news for the move. What the price already reflects: at $254.03 on 12 November 2026 the shares sit 46.4% below the $474.02 intraday high of 2 June 2026. The market is pricing in a slowdown that the company's $40.0 billion 2027 outlook does not show.
Bullish and bearish views on Celestica, Inc.
The bull case on Celestica, Inc. (CLS), in brief: results and outlook beat expectations. The bear case: the longer trend still points down.
Bull case
- Results and outlook beat expectations. The 2027 outlook of $40.0 billion revenue and $21.50 adjusted EPS compares with a Benzinga-cited consensus of $35.842 billion and $19.69, per the company's 26 October 2026 release. Fourth-quarter revenue guidance is $6.275–6.575 billion.
- The core segment doubled. Communications and Connectivity Solutions (CCS) revenue rose 102% from a year earlier in the third quarter at an 8.9% segment margin, per the 26 October 2026 earnings call. Advanced Technology Solutions grew 23%.
- Analyst targets sit far above the price. MarketBeat counted two Strong Buy, 21 Buy and one Hold rating on 11 November 2026, with an average target of $445.14. Goldman Sachs reaffirmed a $435 target on 28 October 2026.
- A share repurchase is authorized. On 30 October 2026 Celestica announced Toronto Stock Exchange (TSX) acceptance of a normal course issuer bid for up to 3.13 million shares through 2 November 2027.
- Buyers returned with volume. The shares closed at $222.92 on 9 November 2026, $242.92 on 11 November 2026 and $254.03 on 12 November 2026. Turnover on 11 November 2026 ran 76% above average, per MarketBeat.
Bear case
- The longer trend still points down. The $254.03 close on 12 November 2026 is below the 50-day moving average of $312.76 and the 200-day average of $328.64. The 50-day sits below the 200-day.
- Free cash flow guidance was cut. TIKR reported on 3 November 2026 that Celestica lowered its 2026 free cash flow outlook to $460 million from $600 million, mainly to fund working capital ahead of 2027. Management plans 2027 capital spending of $1.5–2.0 billion.
- Targets are still being cut. Bernstein kept Outperform on 9 November 2026 but lowered its target to $340, after setting $495 on 28 October 2026.
- Senior officers sold before the decline. SEC Form 4 filings show Chief Executive Officer Robert Mionis sold 23,396 shares at an average of $364.22 and President Todd Cooper sold 20,118 shares at $360.00 on 23 September 2026, both under Rule 10b5-1 plans.
- Customer concentration. Hyperscaler demand is top-heavy, so one customer's 2027 spending plan can move the $40.0 billion outlook.
Price setup
The shares closed at $254.03 on 12 November 2026, after a closing low of $205.64 on 5 November 2026. The three-month change is −24.2%, measured from the $335.05 close of 14 August 2026. The 52-week intraday high is $474.02, set on 2 June 2026.
The 50-day moving average of $312.76 and the 200-day of $328.64, both as of 12 November 2026, sit well above the price. Between them is the $310 price of the August 2026 share offering. Holders who bought in that offering are underwater, and that supply could meet any further rise toward the averages. A close back above the 50-day average would show the decline turning. Closes that stall below it would leave the trend intact.
Catalysts ahead
- 17 November 2026: Nvidia third-quarter fiscal 2027 results, for the quarter ended 25 October 2026. The main read on AI hardware demand, which has moved Celestica and its peers through the sell-off and the rebound. Strong data-center guidance would favour the shares leading.
- ~28 January 2027 (est.): Celestica fourth-quarter 2026 results. Tests revenue against guidance of $6.275–6.575 billion and the $460 million free cash flow outlook. It also shows whether the $40.0 billion 2027 outlook holds, rises or is cut.
What would change the view
A daily close above $272.07, above every close since the 5 November 2026 low, which would show the rebound carrying the shares ahead of the S&P 500; or fourth-quarter 2026 revenue above the $6.575 billion top of guidance with a raised 2027 outlook.
What it trades with
Celestica trades with AI hardware and server names. TIKR reported on 3 November 2026 that Dell fell 30% and Super Micro 29% over the same month as Celestica's slide, and that Flex and Sanmina fell with Celestica on 22 October 2026. The rebound also tracked the market. On 11 November 2026 the shares closed at $242.92, up from $223.89, in a session Investing.com reported as up 0.8% for the S&P 500 and 1.3% for the Nasdaq. Hyperscaler capital-spending plans and Nvidia's reports are the shared drivers. One sell-off and one rebound are too small a sample to estimate a stable relationship.
The evidence, claim by claim (7)
- Third-quarter 2026 revenue was $5.83 billion and adjusted EPS $3.30, against guidance of $5.25–5.55 billion and $2.88–3.08. Celestica third-quarter 2026 results release (8-K) · as of
- 2027 outlook of $40.0 billion revenue and $21.50 adjusted EPS, against a Benzinga-cited consensus of $35.842 billion and $19.69; fourth-quarter 2026 revenue guidance of $6.275–6.575 billion. Celestica third-quarter 2026 results release (8-K); Benzinga · as of
- Celestica cut its 2026 free cash flow outlook to $460 million from $600 million, mainly to fund working capital for 2027. TIKR, 3 November 2026 · as of
- The TSX accepted a normal course issuer bid allowing Celestica to repurchase up to 3.13 million shares through 2 November 2027. Celestica press release, 30 October 2026 · as of
- Bernstein maintained Outperform and lowered its price target to $340, from $495 set on 28 October 2026. Bernstein target action, reported by MarketBeat and Benzinga · as of
- MarketBeat counted two Strong Buy, 21 Buy and one Hold rating, with an average price target of $445.14; volume on 11 November 2026 was about 4.44 million shares, 76% above average. MarketBeat, 11 November 2026 · as of
- CEO Robert Mionis sold 23,396 shares at an average of $364.22 and President Todd Cooper sold 20,118 shares at $360.00, both under Rule 10b5-1 plans. SEC Form 4 filings dated 24 September 2026 · as of
Sources
- Celestica (NYSE:CLS) Stock Jumps 8.3% - What's Next? · marketbeat.com ·
- Celestica Lost 36% in a Month. CIBC Sees 101% Upside From Here · tikr.com ·
- NVIDIA Sets Conference Call for Third Quarter Financial Results · investor.nvidia.com
- Why is Celestica stock rallying today? · investing.com ·
Related · shared themes
AMD
Advanced Micro Devices
Advanced Micro Devices is modestly more likely than not to beat the S&P 500: Helios AI racks and doubling server-processor sales back a $17…
ANET
Arista Networks
Arista Networks' guide for about $18.5 billion of 2027 revenue, near 40% growth, gives its shares a modest edge over the S&P 500 after a…
AVGO
Broadcom
Broadcom's shares look modestly more likely to beat the S&P 500 over three months as Nvidia's CEO exit and Anthropic's near-priced IPO draw…
CBRS
Cerebras Systems
Cerebras Systems is modestly more likely to beat the S&P 500 over three months after guiding fourth-quarter core revenue to $310–330…